Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 115

1.

Plant expression, lyophilisation and storage of HBV medium and large surface antigens for a prototype oral vaccine formulation.

Pniewski T, Kapusta J, Bociąg P, Kostrzak A, Fedorowicz-Strońska O, Czyż M, Gdula M, Krajewski P, Wolko B, Płucienniczak A.

Plant Cell Rep. 2012 Mar;31(3):585-95. doi: 10.1007/s00299-011-1223-7. Epub 2012 Jan 14.

2.

Low-dose oral immunization with lyophilized tissue of herbicide-resistant lettuce expressing hepatitis B surface antigen for prototype plant-derived vaccine tablet formulation.

Pniewski T, Kapusta J, Bociąg P, Wojciechowicz J, Kostrzak A, Gdula M, Fedorowicz-Strońska O, Wójcik P, Otta H, Samardakiewicz S, Wolko B, Płucienniczak A.

J Appl Genet. 2011 May;52(2):125-36. doi: 10.1007/s13353-010-0001-5. Epub 2010 Nov 23.

3.

Freeze-drying of plant tissue containing HBV surface antigen for the oral vaccine against hepatitis B.

Czyż M, Dembczyński R, Marecik R, Wojas-Turek J, Milczarek M, Pajtasz-Piasecka E, Wietrzyk J, Pniewski T.

Biomed Res Int. 2014;2014:485689. doi: 10.1155/2014/485689. Epub 2014 Oct 12.

4.

Stability of S-HBsAg in long-term stored lyophilised plant tissue.

Czyż M, Dembczyński R, Marecik R, Pniewski T.

Biologicals. 2016 Mar;44(2):69-72. doi: 10.1016/j.biologicals.2015.12.001. Epub 2016 Jan 7.

PMID:
26774819
5.

Micropropagation of transgenic lettuce containing HBsAg as a method of mass-scale production of standardised plant material for biofarming purposes.

Pniewski T, Czyż M, Wyrwa K, Bociąg P, Krajewski P, Kapusta J.

Plant Cell Rep. 2017 Jan;36(1):49-60. doi: 10.1007/s00299-016-2056-1. Epub 2016 Sep 21.

6.

Immunogenicity of parenterally delivered plant-derived small and medium surface antigens of hepatitis B virus.

Fedorowicz-Strońska O, Kapusta J, Czyż M, Kaczmarek M, Pniewski T.

Plant Cell Rep. 2016 May;35(5):1209-12. doi: 10.1007/s00299-016-1944-8. Epub 2016 Feb 23.

7.

Applications of human hepatitis B virus preS domain in bio- and nanotechnology.

Toita R, Kawano T, Kang JH, Murata M.

World J Gastroenterol. 2015 Jun 28;21(24):7400-11. doi: 10.3748/wjg.v21.i24.7400. Review.

8.

Expression of the human hepatitis B virus large surface antigen gene in transgenic tomato plants.

Lou XM, Yao QH, Zhang Z, Peng RH, Xiong AS, Wang HK.

Clin Vaccine Immunol. 2007 Apr;14(4):464-9. Epub 2007 Feb 21.

9.

Virus-like particle expression and assembly in plants: hepatitis B and Norwalk viruses.

Huang Z, Elkin G, Maloney BJ, Beuhner N, Arntzen CJ, Thanavala Y, Mason HS.

Vaccine. 2005 Mar 7;23(15):1851-8.

PMID:
15734055
10.

Oral immunization of animals with transgenic cherry tomatillo expressing HBsAg.

Gao Y, Ma Y, Li M, Cheng T, Li SW, Zhang J, Xia NS.

World J Gastroenterol. 2003 May;9(5):996-1002.

11.

Expression and immunoactivity of chimeric particulate antigens of receptor binding site-core antigen of hepatitis B virus.

Yang HJ, Chen M, Cheng T, He SZ, Li SW, Guan BQ, Zhu ZH, Gu Y, Zhang J, Xia NS.

World J Gastroenterol. 2005 Jan 28;11(4):492-7.

12.

Transgenic lettuce seedlings carrying hepatitis B virus antigen HBsAg.

Marcondes J, Hansen E.

Braz J Infect Dis. 2008 Dec;12(6):469-71.

13.

Phase I clinical trial in healthy adults of a nasal vaccine candidate containing recombinant hepatitis B surface and core antigens.

Betancourt AA, Delgado CA, Estévez ZC, Martínez JC, Ríos GV, Aureoles-Roselló SR, Zaldívar RA, Guzmán MA, Baile NF, Reyes PA, Ruano LO, Fernández AC, Lobaina-Matos Y, Fernández AD, Madrazo AI, Martínez MI, Baños ML, Alvarez NP, Baldo MD, Mestre RE, Pérez MV, Martínez ME, Escobar DA, Guanche MJ, Cáceres LM, Betancourt RS, Rando EH, Nieto GE, González VL, Rubido JC.

Int J Infect Dis. 2007 Sep;11(5):394-401. Epub 2007 Jan 24.

14.

Impact of hepatitis B virus (HBV) preS/S genomic variability on HBV surface antigen and HBV DNA serum levels.

Pollicino T, Amaddeo G, Restuccia A, Raffa G, Alibrandi A, Cutroneo G, Favaloro A, Maimone S, Squadrito G, Raimondo G.

Hepatology. 2012 Aug;56(2):434-43. doi: 10.1002/hep.25592. Epub 2012 Jul 13.

PMID:
22271491
15.

PreS antigen expression and anti-preS response in hepatitis B virus infections: relationship to serum HBV-DNA, intrahepatic HBcAg, liver damage and specific T-cell response.

Petit MA, Capel F, Zoulim F, Dubanchet S, Chemin I, Penna A, Ferrari C, Trépo C.

Arch Virol Suppl. 1992;4:105-12.

PMID:
1280500
16.

Optimisation of secretion of recombinant HBsAg virus-like particles: Impact on the development of HIV-1/HBV bivalent vaccines.

Michel M, Lone YC, Centlivre M, Roux P, Wain-Hobson S, Sala M.

Vaccine. 2007 Feb 26;25(10):1901-11. Epub 2006 Aug 22.

PMID:
17005303
17.
18.

Expression, purification and characterization of the Hepatitis B virus entire envelope large protein in Pichia pastoris.

Han X, Ye LB, Li BZ, Bo G, Cai WJ, Hong Z, She YL, Li Y, Kong LB, Wu ZH.

Protein Expr Purif. 2006 Oct;49(2):168-75. Epub 2006 May 20.

PMID:
16829133
19.

Discrimination of hepatitis B virus (HBV) subtypes using monoclonal antibodies to the PreS1 and PreS2 domains of the viral envelope.

Mimms LT, Floreani M, Tyner J, Whitters E, Rosenlof R, Wray L, Goetze A, Sarin V, Eble K.

Virology. 1990 Jun;176(2):604-19.

PMID:
1693248
20.

Overexpression of hepatitis B virus surface antigens including the preS1 region in a serum-free Chinese hamster ovary cell line.

Holzer GW, Mayrhofer J, Leitner J, Blum M, Webersinke G, Heuritsch S, Falkner FG.

Protein Expr Purif. 2003 May;29(1):58-69.

PMID:
12729726

Supplemental Content

Support Center